July 1, 2022

Volume XII, Number 182

Advertisement
Advertisement

July 01, 2022

Subscribe to Latest Legal News and Analysis

June 30, 2022

Subscribe to Latest Legal News and Analysis

June 29, 2022

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Date Title Organization
1
Jul
SCOTUS Raises the Bar for Proof of Intent Under the Controlled Substances Act ArentFox Schiff LLP
1
Jul
FDA Webinar on Genome-Edited Animals for Food Use Keller and Heckman LLP
1
Jul
Health Canada Issues Front-Of-Pack Labeling Regulation Keller and Heckman LLP
1
Jul
Connecticut Update: Recreational Marijuana, Captive Audience Meetings, and Leave Notices Requirements Take Effect July 1, 20 Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
30
Jun
PBMs Continue to Draw Federal Scrutiny: PBM Transparency Act of 2022 Mintz
30
Jun
Final Revision to HBCD Risk Determination Finds HBCD, as a Whole Chemical Substance, Presents an Unreasonable Risk Bergeson & Campbell, P.C.
30
Jun
How the Pharmacy Audit Appeals Process Works Oberheiden P.C.
30
Jun
Now I Know My CBDs – Louisiana Court Favors Employee Terminated for Failing Marijuana Test Bradley Arant Boult Cummings LLP
29
Jun
Time Is Not Always Money: Ninth Circuit Holds That Pre-Employment Drug Testing Is Not Compensable Under California Law Sheppard, Mullin, Richter & Hampton LLP
29
Jun
California District Court Finds that EKRA Applies to Compensation Methodologies for Labs’ Employed Marketers Who Market to Physicians Sheppard, Mullin, Richter & Hampton LLP
29
Jun
Georgia Court Finds Dietary Supplement Labeling Claim within FDA’s Jurisdiction Keller and Heckman LLP
29
Jun
Congress Is Fully Funding EPA's Implementation of Its PFAS Road Map but Insisting on Knowing when EPA Will Get to Its PFAS Destinations Mintz
28
Jun
Supreme Court’s Mens Rea Decision in Drug Case May Have Significant Implications for False Claims Act Cases Based on Anti-Kickback Violations Greenberg Traurig, LLP
28
Jun
Senate Committee Passes the FDA Safety and Landmark Advancements Act Keller and Heckman LLP
28
Jun
DC City Council Enacts Major New Workplace Protections for Marijuana Users ArentFox Schiff LLP
28
Jun
Senate Committee Passes the FDA Safety and Landmark Advancements Act Keller and Heckman LLP
28
Jun
EPA Announces New Chemical Engineering Initiative Intended to Increase Transparency and Reduce Rework Bergeson & Campbell, P.C.
27
Jun
PFAS Regulations Could Open Floodgates to Prop 65 Enforcement – Assess & Manage Your Exposure Now Sheppard, Mullin, Richter & Hampton LLP
27
Jun
Supreme Court Rules for Physicians in Blow to DOJ Sheppard, Mullin, Richter & Hampton LLP
27
Jun
CMS Releases Cy 2023 End-Stage Renal Disease Prospective Payment System Proposed Rule McDermott Will & Emery

Pages